Loading…
Loading…
EQUITY / NYSE · XASE
OS Therapies Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.62 USD · 1.25%
Observed: Oct 5, 2026, 11:45 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 1.6 USD · Volume 416,213
63 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -8,575,612 USD | -4,838,728 USD | — |
| Net income | -8,632,386 USD | -4,536,622 USD | — |
| Total liabilities | 20,741,243 USD | — | — |
| Total equity | -11,914,635 USD | 4,943,647 USD | -341.01% |
| Total assets | 9,897,313 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -8,632,386 USD | -19,029,217 USD | -10,396,831 USD | — | -28,753,844 USD | -6,879,530 USD | -15,293,011 USD | -4,536,622 USD |
| Operating profitIncome statement | -8,575,612 USD | -18,743,550 USD | — | — | -28,705,701 USD | -6,879,595 USD | -16,717,809 USD | -4,838,728 USD |
| Total assetsBalance sheet | 9,897,313 USD | — | — | 6,839,534 USD | 6,839,534 USD | 8,953,251 USD | — | — |
| Total equityBalance sheet | -11,914,635 USD | — | -10,824,238 USD | -6,095,631 USD | -6,095,631 USD | 3,637,195 USD | — | 4,943,647 USD |
| Total liabilitiesBalance sheet | 20,741,243 USD | — | — | 11,864,460 USD | 11,864,460 USD | 4,245,351 USD | — | — |
| Financing cash flowCash flow statement | — | 10,031,615 USD | — | — | 9,441,302 USD | — | 7,317,852 USD | — |
| Operating cash flowCash flow statement | — | -10,096,410 USD | — | — | -14,238,576 USD | — | -10,508,330 USD | — |
| Capital expendituresCash flow statement | — | — | — | — | 466,423 USD | — | 466,423 USD | — |
| Investing cash flowCash flow statement | — | — | — | — | -466,423 USD | — | -466,423 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.